Salvage Therapy for Prostate Cancer

1. Auflage 2021
ISBN: 978-3-030-57180-1
Verlag: Springer International Publishing

Buch, Englisch, 266 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 652 g

This book comprehensively covers application of salvage therapy in reccurrent prostate cancer. Chapters focus on specific issues associated with a range of surgical and oncological management techniques and strategies including hormone therapy, lymphnode dissection, robotic  prostatectomy and salvage reirradiation after locoregional failure. Learning objectives, and definitions of keywords are provided to aid the reader develop a thorough understanding of the topic and reinforce the key points covered in each chapter.   
Salvage Therapy for Prostate Cancer
provides a detailed practically applicable guide  on how salvage therapy can be utilised in the treatment of prostate cancer. It represents a valuable resource for trainee and practicing urologists, oncologists, and specialist nurses.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Goonewardene, Sanchia S.

Persad, Raj

Cahill, Declan

Ventii, Karen

Albala, David

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Onkologische Chirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Urologie, Andrologie, Venerologie

Inhaltsverzeichnis

Systematic Review of Open, Laparoscopic and Robotic Salvage Radical Prostatectomy.- Salvage Prostatectomy for Radio-recurrent Prostate Cancer.- Salvage Robot-Assisted Radical Prostatectomy for Recurrent Localized Prostate Cancer after Radiation Therapy- Pre-operative Assessment, the contribution of Robotics and Outcomes.- Disease Recurrence after Radical Prostatectomy.- Salvage Therapy in Prostate Cancer- Predictors of Recurrence.- The Role of MRI in Recurrent Prostate Cancer.- Clinical Staging/Diagnostic Imaging.- Imaging for Salvage Therapy in Recurrent Prostate Cancer.- The Role of PET in Salvage Therapy for Prostate Cancer.- Salvage Radiotherapy.- Salvage Cryotherapy in Prostate Cancer.- Salvage Treatment after Focal Therapy.- Salvage Re-Irradiation after Locoregional Failure with Primary Radiotherapy for Prostate Cancer.- Salvage Brachytherapy- Outcomes from Low and High dose Brachytherapy in Prostate Cancer.- Salvage Brachytherapy after Primary Brachytherapy in Recurrent Prostate Cancer.- Focal Salvage Therapy for Prostate Cancer Recurrence after Primary Radiotherapy.- Salvage Lymph Node Dissection.- Salvage Re-irradiation Therapy after Loco-regional Failure for Radiotherapy.- Role of Metastasectomy in Prostate Cancer Patients following Primary Treatment.- Incontinence of Urine after the Treatment of Prostate Cancer.- Erectile Dysfunction in Salvage Prostate Cancer Therapies.

Über Autor(innen)

Sanchia Goonewardene qualified from Birmingham Medical School with Honours in Clinical Science and a BMedSc Degree in Medical Genetics and Molecular Medicine. She has 627 publications and has published 4 books. She is an Associate Member of EAU Guideslines Panel on Chronic Pelvic Pain. She is Section Editor  for Urology with JORS, and on the Editorial Board of The World Journal of Urology. She is an Alumni of the Urology Foundation, and is on the working group of The International Continence Society Terminology Panel on Pelvic Floor Dysfunction and also the Good Urodynamic Practice Panel. She is currently a Urology Spr with East of England Deanery.

Dr Karen Ventii is a Harvard-trained specialist in healthcare communications, with over 10 years of experience in oncology and urology. As a Visiting Fellow at Harvard University, she conducted independent research on evolving trends in continuing medical education, with the aim of diminishing the gap between evidence andpractice. 

David M Albala, MD  is Chief of Urology at Crouse Hospital in Syracuse, New York.  He is considered a national and international authority in laparoscopic and robotic urological surgery and has been an active teacher in this area for over 20 years.  His research and clinical interest have focused on robotic urologic surgery.  In addition, other clinical interest includes minimally invasive treatments for benign prostatic hypertrophy (BPH) and the use of fibrin sealants in surgery.  

Declan Cahill is a Consultant Urologist based at the Royal Marsden Hospital. His focus is prostate cancer diagnostics and robotics. He was appointed to the Marsden in 2015 and previously worked at Guys and St Thomas Hospitals. He has operated on over 3000 prostates to date.